Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 288-290

  Kennedy, Alexander W ^a   Markman, Maurie ^a   Webster, Kenneth D ^a   Kulp, Barbara ^a   Peterson, Gert ^a   Rybicki, Lisa A ^a   Belinson, Jerome L ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; PLATINUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; EXPERIENCE; FEMALE; HUMAN; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032213197     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5159     Document Type: Article

References (13)

1. Mills S E, Anderson W A, Fechner R E, Austin M B. Serous surface papillary carcinoma: A clinico-pathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma. Am J Surg Pathol. 12:1988;827-834.
2. Fromm G L, Gershenson D M, Silva E G. Papillary serous carcinoma of the peritoneum. Obstet Gynecol. 75:1990;89-95.
3. Ransom D T, Patel S R, Keeney G L, Markasian G D, Edmonson J H. Papillary serous carcinoma of the peritoneum: A review of 33 cases treated with platin based chemotherapy. Cancer. 66:1990;1091-1094.
4. Bloss J D, Liao S Y, Buller R E, Manetta A, Berman M L, McMeekin S, Bloss L P, DiSaia P J. Extraovarian peritoneal serous papillary carcinoma: A case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 50:1993;347-351.
5. Killackey M A, Davis A R. Papillary serous carcinoma of the peritoneal surface: Matched-case comparison with papillary serous ovarian carcinoma. Gynecol Oncol. 51:1993;171-174.
6. Fowler J M, Nieberg R K, Schooler T A, Berek J S. Peritoneal adenocarcinoma (serous) of mullerian origin: A subgroup of women presenting with peritoneal carcinomatosis. Int J Gynecol Cancer. 4:1994;43-51.
7. Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Siedman D S. Primary peritoneal serous papillary carcinoma: A study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma. Gynecol Oncol. 60:1996;393-396.
8. McGuire W P, Hoskins W J, Brady M F, Kucera P R, Partridge E E, Look K Y, Clarke-Pearson D L, Davidson M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 334:1996;1-6.
9. Menzin A W, Aikins J K, Wheeler J E, Rubin S C. Surgically documented responses to paclitaxel and cisplatin in patients with primary peritoneal carcinoma. Gynecol Oncol. 62:1996;55-58.
10. Piver M S, Eltabbakh G H, Hempling R E, Recio O F, Blumenson L E. Two sequential studies for primary peritoneal carcinoma: Induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol. 67:1997;141-146.
11. Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: The Cleveland Clinic experience. Semin Oncol. 24:1997;S15-26-S15-29.
12. Dalrymple J C, Bannatyne P, Solomon H J, Tattersall M H, Atkinson K, Carter J, Duval P, Elliott P, Friedlander M. Extraovarian peritoneal serous papillary carcinoma: A clinicopathologic study of 31 cases. Cancer. 64:1989;110-115.
13. Meyer J, Kennedy A W, Friedman R, Ayoub A, Zepp R C. CT predicted outcome of cytoreductive surgery for ovarian carcinoma. Radiology. 165:1995;875-878.